As of 4:00pm ET
| +0.0724 / +11.14%|
The 5 analysts offering 12-month price forecasts for Anthera Pharmaceuticals Inc have a median target of 1.00, with a high estimate of 3.00 and a low estimate of 0.90. The median estimate represents a +38.43% increase from the last price of 0.72.
The current consensus among 5 polled investment analysts is to Hold stock in Anthera Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.